Clinical Interventions

Individuals with mental illness and addiction comprise at least half of the patients in most mental health treatment systems. This combination results in increased risk for frequent psychiatric relapses, poor medication compliance, violence, suicide, legal problems, and high utilization of the emergency room or inpatient services. Traditional mental health and addiction treatments have not adequately addressed these co-occurring disorders due to clinical interventions, programs, and system flaws that have not addressed the individual's needs. Integrated treatment requires both an understanding of mental illness and addiction and the means to integrate and modify the traditional treatment approaches in both the mental health and addiction treatment fields. There is strong evidence to support the efficacy and effectiveness of integrated treatment in this population. All mental health clinicians should become experienced and skilled in the core psychotherapy approaches to treating substance use disorders, including motivational enhancement therapy, relapse prevention, and 12-step facilitation. In addition, integrated treatment includes integrating medications for both addiction and mental illness with the behavioral therapies and other psychosocial interventions.

Recent clinical studies have shown that between 30% and 60% of drug abusers have mental health diagnoses Depression, Schizophrenia, and Manic illness disorders. Drug Addiction is a typical of disorder involves the interaction of environmental factors and genetic factors to increase the susceptibility of an individual to addictive behaviour. SAMHA scientists are working on the pharmacological and neuropsychosocial models and approaches that involve preclinical studies and clinical findings, to explain the effects of mental health and physical disorders and outcomes in addicted persons. Researchers focus on pregnant women smokes cigarettes. Tobacco usage elevates therapeutic and behavioural therapies in smokers with concurrent psychiatric disorders. Scientists are developing interventions using pharmacological and behavioural treatments in alcohol and chemical dependence. The overall goal of the research is to participate and conduct high-quality multi-site clinical trials for drug abuse and addiction, for the development, and adoption of effective approaches in this field.

  • Mental Health
  • Emotional health
  • Behavioral health sciences
  • Spiritual sciences
  • Psychology and Education
  • Motivational interviewing
  • Contingency management
  • Residential treatment
  • Psychodynamic therapy
  • Dialectical behavioral therapy
  • Cognitive impairment

Related Conference of Clinical Interventions

September 26-27, 2018

28th World Summit on Neurology, Neuroscience and Neuropharmacology

Montreal, Quebec, Canada
October 18-19, 2018,

27th International Conference on Neurology and Cognitive Neuroscience

Radisson Blu Sobieski Hotel, Warsaw, Poland
November 1-2, 2018

4th International Conference on Spine Surgery

Brussels, Belgium
November 12-13, 2018

5th Annual Conference on Stroke and Neurological Disorders

Istanbul, Turkey
November 12-13, 2018

International conference on Dual Diagnosis and Disorders

Melbourne, Australia
November 12-13, 2018

30th International Conference on Mental and Behavioral Health

Melbourne, Australia
November 12-13, 2018

25th Cognitive Neuroscience Congress

Dubai, UAE
November 16-17, 2018

4th World Congress on Epilepsy and Treatment

Tokyo, Japan
November 16-17, 2018

18th Global Neuroscience Conference

Tokyo, Japan
November 19-20, 2018

8th International Congress on Stroke and Neurology

Paris | France
November 22-23, 2018

World Congress on Epilepsy and Brain Disorders

Cape Town, South Africa
November 26-27, 2018

World Neuron Congress

Helsinki, Finland
December 5-7, 2018

World Brain Congress

Dubai, UAE
December 13-15, 2018

13th Annual Conference on Dementia and Alzheimers Disease

Abu Dhabi, UAE
February 15-16, 2019

11th International Conference on Vascular Dementia

Amsterdam| Netherlands
February 28 – March 02, 2019

28th World Congress on Neurology and Therapeutics

Berlin, Germany
March 14-15, 2019

Annual Congress on Neurology & Neuroscience

Paris, France
March 18-19, 2019

World Depression Congress

Dubai, UAE
March 20-21, 2019

11th World Congress on Alzheimers Disease & Dementia

Sydney, Australia
March 25-26, 2019

8th International Conference on Psychoneuroimmunology

Bucharest, Romania
March 25-26, 2019

31st World Congress on Neurology & Neuroscience

Osaka, Japan
April 11-12, 2019

International Conference on Neurology & Mental Disorders

Stockholm, Sweden
April 22-23, 2019

26th World Congress on Neurology and Neurodisorders

| Radisson Hotel Narita, Tokyo, Japan
May 23-24, 2019

28th World Congress on Neurology & Neuroscience

Zurich, Switzerland
June 17-18, 2019

9th International Conference on Addictive Disorders and Alcoholism

Novotel Brisbane, Australia
June 21-22, 2019

American Neuroscience and Neurosurgery Congress

Ottawa, Canada
July 22-23, 2019

World Congress on Down Syndrome, Autism & Cerebral Palsy

Melbourne, Australia
July 22-24, 2019

32nd European Neurology Congress

London, UK
August 19-20, 2019

5th International Conference on Epilepsy & Treatment

Vienna, Austria
August 19-20, 2019

5th World Congress on Parkinsons & Huntington Disease

Vienna, Austria
October 21-22, 2019

World Congress on Advances in Brain Injury, Disorders and Therapeutics

| Radisson Hotel Narita, Tokyo, Japan
November 19-20, 2019

32nd Clinical Neuroscience and Neurogenetics Conference

Istanbul, Turkey

Clinical Interventions Conference Speakers

Recommended Sessions

Related Journals

Are you interested in